PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FROM LONGER TREATMENT OR UPDOSING WITH OMALIZUMAB.

Details

Language :

English

ISSN :

10811206

Volume :

129

Issue :

5

Database :

Supplemental Index

Journal :

Annals of Allergy, Asthma & Immunology

Publication Type :

Academic Journal

Accession number :

159656663

Full Text :

https://doi.org/10.1016/j.anai.2022.08.534